Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Approved
Development Phase
0
Upcoming Catalysts
0
Historical Events
2
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Hemophilia A
Mechanism of Action
Gene Therapy
Clinical Trial
NCT03370913Last updated: 12/3/2025
No patent data available. Pre-approval drugs may not have Orange Book listings.
Roctavian
Treatment of severe haemophilia A (congenital factor VIII deficiency) in adult patients without a history of factor VIII inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (AAV5).
Phenylketonurias
Mucopolysaccharidosis IV A
Pain, Post-operative
Anemia Associated With End Stage Renal Disease
Hemophilia A With Inhibitor